- Home
- VET vs CRMD Comparison
VET vs CRMD Comparison
Compare VET & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VET
- CRMD
- Stock Information
- Founded
- VET 1994
- CRMD 2006
- Country
- VET Canada
- CRMD United States
- Employees
- VET N/A
- CRMD N/A
- Industry
- VET Oil & Gas Production
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- VET Energy
- CRMD Health Care
- Exchange
- VET Nasdaq
- CRMD Nasdaq
- Market Cap
- VET 961.0M
- CRMD 877.5M
- IPO Year
- VET N/A
- CRMD 2010
- Fundamental
- Price
- VET $7.47
- CRMD $10.35
- Analyst Decision
- VET
- CRMD Strong Buy
- Analyst Count
- VET 0
- CRMD 7
- Target Price
- VET N/A
- CRMD $17.33
- AVG Volume (30 Days)
- VET 870.9K
- CRMD 2.4M
- Earning Date
- VET 08-07-2025
- CRMD 08-07-2025
- Dividend Yield
- VET 4.58%
- CRMD N/A
- EPS Growth
- VET N/A
- CRMD N/A
- EPS
- VET N/A
- CRMD 0.79
- Revenue
- VET $1,296,504,678.00
- CRMD $121,484,498.00
- Revenue This Year
- VET $27.92
- CRMD $278.96
- Revenue Next Year
- VET N/A
- CRMD $45.85
- P/E Ratio
- VET N/A
- CRMD $13.66
- Revenue Growth
- VET 3.24
- CRMD 14970.29
- 52 Week Low
- VET $5.14
- CRMD $3.61
- 52 Week High
- VET $10.85
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- VET 42.62
- CRMD 32.89
- Support Level
- VET $7.73
- CRMD $9.61
- Resistance Level
- VET $8.16
- CRMD $12.09
- Average True Range (ATR)
- VET 0.26
- CRMD 0.72
- MACD
- VET -0.09
- CRMD -0.06
- Stochastic Oscillator
- VET 3.88
- CRMD 12.02
About VET Vermilion Energy Inc. Common (Canada)
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.